CergenX | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

86 results for “CergenX”

Trials

View all 17 →

Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff Tendinopathy

52 participants · First posted Dec 2, 2024

Active, not recruiting

Feasibility of Delivering VergeRx at FQHCs

100 participants · First posted Dec 8, 2023

Bergen Oral Respiratory Intervention Study

62 participants · First posted Mar 4, 2021

Drugs

View all 22 →

EpiPros1 (Celgene Corp.)

SP-100207 (Celgene)

CSC1 (Celgene Corp.)

Organizations

View all 22 →

Ceregene, Inc.

United States

CELGENE CORPORATION

United States

CELGENE CORP

United States

News

View all 25 →

CergenX's AI-Powered Wave Device Receives FDA Breakthrough Designation for Neonatal Brain Monitoring

Vergent Bioscience Completes Enrollment in Phase 2 Trial of Abenacianine for Enhanced Tumor Visualization During Lung Cancer Surgery

Vergent Bioscience Completes Phase 2 Trial Enrollment of Abenacianine for Enhanced Lung Tumor Visualization

Page 1 of 9